Specific keynote: molecular therapeutics in ovarian cancer.

Gordon B. Mills, Xianjun Fang, Yiling Lu, Yutaka Hasegawa, Astrid Eder, Janos Tanyi, Fazad Haq Tabassam, Muling Mao, Hongwei Wang, Kwai Wa Cheng, Yasuhisa Nakayama, Wenlin Kuo, Jim Erickson, David Gershenson, Elise C. Kohn, Robert Jaffe, Robert C. Bast, Joe Gray

Research output: Contribution to journalReview article

18 Scopus citations
Original languageEnglish (US)
Pages (from-to)S88-92; discussion S93-96
JournalGynecologic oncology
Volume88
Issue number1 Pt 2
DOIs
StatePublished - Jan 2003

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Mills, G. B., Fang, X., Lu, Y., Hasegawa, Y., Eder, A., Tanyi, J., Tabassam, F. H., Mao, M., Wang, H., Cheng, K. W., Nakayama, Y., Kuo, W., Erickson, J., Gershenson, D., Kohn, E. C., Jaffe, R., Bast, R. C., & Gray, J. (2003). Specific keynote: molecular therapeutics in ovarian cancer. Gynecologic oncology, 88(1 Pt 2), S88-92; discussion S93-96. https://doi.org/10.1006/gyno.2002.6692